Commission Recommendation (EU) 2020/1743 on the use of rapid antigen tests for the diagnosis of SARS-CoV-2 infection

Summary:

Recommendation adopted by the European Commission on 18 November 2020, setting out guidance for Member States regarding the use of rapid antigen tests to detect SARS-CoV-2 infection. This is in the context of the COVID-19 (coronavirus) pandemic.

Further information:

This Recommendations builds on previous guidance published by the Commission on COVID-19 testing strategies. It recommends Member States to conduct rapid antigen tests in addition to RT-PCR tests in clearly defined settings where the deployment of antigen tests is appropriate, and with the aim to contain the spread of the coronavirus, to detect SARS-CoV-2 infections and to limit isolation and quarantine measures.

The guidance also contributes to ensuring the free movement of persons and the smooth functioning of the internal market, in times of limited testing capacities. In particular, the Recommendation focuses on criteria to be used for the selection of rapid antigen tests, the settings during which rapid antigen tests are appropriate to be used, test operators, and validation and mutual recognition of rapid antigen tests and their results.

• Alternative Source 1

Official

European Commission: Press Release, 18/11/2020: Coronavirus: Commission steps up actions on testing with a recommendation on rapid antigen tests and support to increase testing capacity https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2047

---